Vir Biotechnology, Inc. (VIR)
10.71
+0.80
(+8.07%)
USD |
NASDAQ |
Aug 25, 16:00
10.90
+0.19
(+1.77%)
After-Hours: 05:38
Vir Biotechnology Price : 10.71 for Aug. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 10.03 | 11.28 | 9.97 | 10.71 | 2.961M |
| Aug 24, 2026 | 9.74 | 9.975 | 9.435 | 9.91 | 1.740M |
| Aug 21, 2026 | 9.31 | 9.86 | 9.305 | 9.78 | 1.756M |
| Aug 20, 2026 | 9.61 | 9.71 | 9.025 | 9.21 | 1.061M |
| Aug 19, 2026 | 9.86 | 10.08 | 9.54 | 9.77 | 2.086M |
| Aug 18, 2026 | 9.27 | 9.50 | 9.24 | 9.49 | 1.481M |
| Aug 17, 2026 | 9.23 | 9.49 | 9.17 | 9.39 | 1.461M |
| Aug 14, 2026 | 9.00 | 9.27 | 8.80 | 9.24 | 1.016M |
| Aug 13, 2026 | 9.02 | 9.20 | 8.883 | 9.00 | 1.246M |
| Aug 12, 2026 | 8.89 | 9.09 | 8.855 | 8.96 | 984213.0 |
| Aug 11, 2026 | 8.96 | 9.01 | 8.771 | 8.93 | 1.203M |
| Aug 10, 2026 | 8.80 | 9.03 | 8.79 | 8.89 | 1.487M |
| Aug 07, 2026 | 8.87 | 9.03 | 8.75 | 8.82 | 1.663M |
| Aug 06, 2026 | 9.699 | 9.699 | 8.615 | 8.765 | 2.603M |
| Aug 05, 2026 | 9.19 | 9.36 | 9.00 | 9.11 | 1.453M |
| Aug 04, 2026 | 9.02 | 9.275 | 8.93 | 9.17 | 1.709M |
| Aug 03, 2026 | 8.91 | 9.06 | 8.545 | 8.90 | 1.242M |
| Jul 31, 2026 | 8.95 | 8.96 | 8.535 | 8.66 | 1.127M |
| Jul 30, 2026 | 8.61 | 8.995 | 8.61 | 8.90 | 1.197M |
| Jul 29, 2026 | 8.84 | 8.97 | 8.55 | 8.64 | 1.413M |
| Jul 28, 2026 | 8.83 | 8.885 | 8.52 | 8.85 | 1.391M |
| Jul 27, 2026 | 8.82 | 9.085 | 8.77 | 8.80 | 1.688M |
| Jul 24, 2026 | 9.00 | 9.15 | 8.62 | 8.69 | 2.152M |
| Jul 23, 2026 | 9.21 | 9.466 | 9.16 | 9.34 | 1.515M |
| Jul 22, 2026 | 9.38 | 9.59 | 9.30 | 9.35 | 1.452M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Caribou Biosciences, Inc. | 1.76 |
| Arrowhead Pharmaceuticals, Inc. | 88.88 |
| Oncolytics Biotech, Inc. | 0.8614 |
| Sangamo Therapeutics, Inc. | 0.1489 |
| Sarepta Therapeutics, Inc. | 18.92 |
Price Related Metrics
| PS Ratio | 5.248 |
| Price to Book Value | 1.844 |
| Earnings Yield | -17.38% |
| Market Cap | 1.812B |